Despite the recent attention to the potential of developing and using gene therapy to treat several diseases, the therapy was ...

The Eye Care Network sat down with Rajesh K. Rajpal, MD, ophthalmologist and founder of See Clearly Vision Group in McLean, Virginia, to discuss what this novel therapeutic means for managing ...

Dompé was selected by the US Food and Drug Administration (FDA) to participate in the Commissioner’s National Priority ...

Glaukos announced that the FDA has approved the new drug application for its topical drug therapy (Epioxa HD/Epioxa) for ...

The dexamethasone insert effectively treats postoperative inflammation and allergic conjunctivitis, with a favorable safety ...

Aurion Biotech has released positive 12-month results from its phase 1/2 CLARA trial evaluating the safety, efficacy, and ...

Bedrood describes improved visualization of the ciliary body, efficient setup, and favorable postoperative outcomes.

Phase 2 STARLIGHT study participants, particularly those with the macular phenotype, experienced meaningful gains in visual ...

Stoke Therapeutics announced 2-year data from the FALCON study, a prospective natural history study in people with autosomal ...

A new study published in Experimental Eye Research reported that the preclinical results achieved with SPG302 (Spinogenix, ...

Ophthalmologists from across the United States and around the globe gathered in Orlando, Florida over the October 17 through ...

John P. Berdahl, MD, a surgeon at Vance Thompson Vision and a professor at the University of South Dakota, spoke on the lens ...